ESR1 and breast cancer: In order to establish the most efficient treatment for patients, the histological classification is completed via the molecular classification of BC that is based on the expression profiles of the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and Ki67 antigen.